Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 30% ± 14% |
Insufficient scRNA-seq data for expression of FBXO27 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 490.72 | 179 / 180 | 83% | 11.02 | 359 / 430 |
kidney | 96% | 355.43 | 85 / 89 | 86% | 9.24 | 773 / 901 |
brain | 99% | 990.96 | 2623 / 2642 | 78% | 6.66 | 550 / 705 |
breast | 95% | 544.85 | 434 / 459 | 82% | 9.70 | 914 / 1118 |
prostate | 97% | 443.36 | 238 / 245 | 77% | 6.48 | 389 / 502 |
liver | 90% | 323.25 | 204 / 226 | 77% | 11.06 | 311 / 406 |
uterus | 78% | 207.36 | 132 / 170 | 82% | 20.60 | 376 / 459 |
bladder | 90% | 535.33 | 19 / 21 | 67% | 21.77 | 338 / 504 |
esophagus | 82% | 562.30 | 1181 / 1445 | 68% | 15.30 | 125 / 183 |
lung | 55% | 170.46 | 320 / 578 | 72% | 23.58 | 833 / 1155 |
skin | 82% | 1549.82 | 1484 / 1809 | 43% | 4.02 | 204 / 472 |
stomach | 81% | 225.73 | 291 / 359 | 20% | 1.39 | 57 / 286 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.89 | 1 / 1 |
pancreas | 38% | 77.03 | 124 / 328 | 56% | 6.31 | 100 / 178 |
adipose | 93% | 627.35 | 1121 / 1204 | 0% | 0 | 0 / 0 |
heart | 83% | 347.48 | 713 / 861 | 0% | 0 | 0 / 0 |
intestine | 63% | 198.71 | 607 / 966 | 15% | 1.15 | 77 / 527 |
adrenal gland | 20% | 45.19 | 52 / 258 | 57% | 5.08 | 130 / 230 |
blood vessel | 75% | 209.47 | 1005 / 1335 | 0% | 0 | 0 / 0 |
thymus | 40% | 87.96 | 263 / 653 | 33% | 2.43 | 199 / 605 |
eye | 0% | 0 | 0 / 0 | 28% | 1.48 | 22 / 80 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.99 | 7 / 29 |
muscle | 5% | 10.18 | 38 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 7.03 | 25 / 929 | 0% | 0 | 0 / 0 |
spleen | 1% | 2.37 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO_0036503 | Biological process | ERAD pathway |
GO_0006516 | Biological process | glycoprotein catabolic process |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXO27 |
Protein name | Epididymis secretory sperm binding protein (F-box protein 27) F-box only protein 27 (F-box/G-domain protein 5) F-box protein 27 |
Synonyms | FBX27 hCG_1997261 FBG5 |
Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Able to recognize and bind denatured glycoproteins, which are modified with complex-type oligosaccharides. . |
Accessions | ENST00000598394.1 ENST00000593847.1 Q8NI29 M0R0I8 A0A384MR61 M0R1C3 ENST00000600828.5 ENST00000292853.9 M0QYQ6 |